MISSION

Advancing Vaccines, Transforming Immunotherapy

BiOMViS leverages Outer Membrane Vesicles (OMVs) to develop innovative vaccines and immunotherapies against infectious diseases and cancer.

BiOMViS VACCINE PLATFORM

The Technology

The BiOMViS Innovation

The Platform Advantages
Founders & Scientific Advisory Board

BiOMViS TEAM

BiOMViS
Prof. Guido Grandi
COO
Maria Raffaella Spalla Grandi, PhD
CEO
BiOMViS
Grandi Alberto, PHD
CSO

SCIENTIFIC ADVISORY BOARD

Scientific Advisory Board
Prof. Dario Neri
Scientific Advisory Board
Scientific Advisory Board
Prof. Martino Bolognesi
Scientific Advisory Board
Scientific Advisory Board
Francesco Berti, PhD
Scientific Advisory Board
Scientific Advisory Board
Prof.ssa Lisa Licitra
Scientific Advisory Board
Scientific Advisory Board
Prof. Massimo Pizzato
Scientific Advisory Board
PIPELINE

BiOMViS Pipeline

Our Pubblications

GET IN TOUCH

Your Name (required)

Your Email (required)

Subject

Your Message

I authorize the processing of my personal data (Regulation UE/679/16); I consent to the processing and storage of my personal data in your filing system in compliance with Regulation (EU) 2016/679 and the conditions stated therein for data transfer.

BiOMViS Srl is located at the Fondazione Toscana Life Sciences (TLS) Scientific Park (Siena, Italy), where it has access to fully equipped laboratories and office space and to a variety of high-tech services, including Flow cytometry, Electron Microscopy, Confocal Microscopy, Proteomic and Mass Spectrometry, Protein Purification.

Contact us

Biomvis srl, Via Fiorentina, 1 - 53100 Siena - Italy
+39 0577 231278